Report Overview
The Global Zygomatic and Pterygoid Implants Market size is expected to be worth around US$ 548.6 Million by 2035 from US$ 276.3 Million in 2025, growing at a CAGR of 7.1% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 41.3% share with a revenue of US$ 114.1 Million.
Zygomatic and pterygoid implants are transforming the field of implant dentistry by offering reliable solutions for patients with severe upper jaw bone loss who may not be suitable candidates for conventional dental implants. These advanced implant techniques eliminate the need for extensive bone grafting procedures while providing a strong foundation for fixed teeth.
Zygomatic implants are longer than traditional implants and are anchored in the dense zygomatic (cheek) bone, ensuring exceptional stability even in cases of significant maxillary bone deficiency. Pterygoid implants, on the other hand, are strategically placed in the pterygoid region at the back of the upper jaw, maximizing available bone support and improving prosthetic outcomes.
Together, these innovative techniques enable immediate or early restoration of function and aesthetics, allowing patients to regain their ability to eat, speak, and smile with confidence. The procedures are particularly beneficial for individuals with advanced bone resorption, failed implants, or those seeking an alternative to sinus lift and bone graft surgeries.
With advancements in digital planning, 3D imaging, and guided implant placement, zygomatic and pterygoid implants offer predictable, long-lasting results and shorter treatment timelines. They represent a significant breakthrough in modern implantology, providing renewed hope and an improved quality of life for patients requiring full-arch dental rehabilitation.
Click here for more information:
https://market.us/report/zygomatic-and-pterygoid-implants-market/
Key Takeaways
- In 2025, the market generated a revenue of US$ 276.3 Million, with a CAGR of 7.1%, and is expected to reach US$ 548.6 Million by the year 2035.
- The material type segment is divided into titanium implants and zirconia implants, with titanium implants taking the lead with a market share of 53.9%.
- Considering application, the market is divided into maxillary bone loss, severe alveolar atrophy, maxillary sinuses and other applications. Among these, maxillary bone loss held a significant share of 55.1%.
- Furthermore, concerning the end user segment, the market is segregated into hospitals, dental clinics, ambulatory surgical centers, academic institutions and others. The dental clinics sector stands out as the dominant player, holding the largest revenue share of 58.6% in the market.
- The distribution channel segment is segregated into direct sales, dental distributors and online channel, with the dental distributors segment leading the market, holding a revenue share of 48.5%.
- North America led the market by securing a market share of 41.3%.
Key Market Segments
By Material Type
Titanium Implants
Zirconia Implants
By Application
Maxillary Bone Loss
Severe Alveolar Atrophy
Maxillary Sinuses
Other Applications
By End User
Hospitals
Dental Clinics
Ambulatory Surgical Centers
Academic Institutions
Others
By Distribution Channel
Direct Sales
Dental Distributors
Online Channel
Top Key Players
Straumann Holding AG
Dentsply Sirona Inc.
Southern Implants
Noris Medical
S.I.N. Implant System
Bioline Dental Implants
B&B Dental Implant Company
IDC Implant and Dental Company
Megagen Implant Co., Ltd.
Emerging Trends
- Growing Use of Digital Treatment Planning: Dental clinics are increasingly using Cone Beam Computed Tomography (CBCT), 3D imaging, and digital planning software before implant surgery. These technologies improve implant positioning and reduce surgical risks. NCBI identifies CBCT as the preferred imaging method for implant planning, supporting more accurate and predictable outcomes.
- Immediate Loading is Becoming More Common: Many specialists now place temporary fixed teeth on the same day or shortly after zygomatic implant surgery. According to the 2023 ITI Consensus Report, immediate loading showed better survival rates than delayed loading, while long-term zygomatic implant survival reached 96.2% over an average follow-up of 75.4 months.
- Reduced Dependence on Bone Grafting: Zygomatic and pterygoid implants are increasingly used to avoid sinus lifts and bone grafting in patients with severe upper jaw bone loss. This trend shortens treatment time, lowers the number of surgeries, and provides faster functional rehabilitation for completely or partially edentulous patients.
- Increased Adoption of Guided Surgery: Computer-guided implant placement and customized surgical guides are improving accuracy for complex implant cases. Healthcare literature shows that image-based planning helps clinicians identify anatomical structures precisely, reducing complications and increasing confidence during zygomatic and pterygoid implant procedures.
- Focus on Long-Term Full-Arch Rehabilitation: Healthcare providers are increasingly selecting zygomatic and pterygoid implants for full-arch fixed prostheses instead of removable dentures. Recent systematic reviews report that 75% of documented pterygoid implants were used to support fixed full-arch restorations, reflecting a growing preference for permanent dental solutions.
Key Use Cases
- Treatment of Severe Upper Jaw Bone Loss: Zygomatic implants are designed for patients with significant maxillary bone atrophy where conventional implants cannot be placed safely. Their anchorage in the cheekbone provides stable support and allows fixed teeth without extensive bone reconstruction procedures.
- Alternative to Sinus Lift Procedures: Pterygoid implants utilize the dense bone behind the upper jaw, helping patients avoid sinus augmentation surgery. This approach reduces treatment stages and allows clinicians to restore missing posterior teeth while preserving available bone structures.
- Full-Mouth Fixed Teeth Rehabilitation: Patients who have lost most or all upper teeth benefit from zygomatic and pterygoid implants supporting full-mouth prostheses. These implants improve chewing ability, speech, and comfort while offering stable long-term support compared with conventional removable dentures.
- Rehabilitation After Failed Conventional Implants: Patients experiencing failed standard implants due to poor bone quality can receive zygomatic or pterygoid implants as an alternative treatment. Their placement in stronger anatomical regions provides improved stability and expands treatment options for complex dental cases.
- Immediate Function for Complex Cases: Many advanced implant centers use zygomatic and pterygoid implants to provide fixed temporary teeth within a short period after surgery. Studies report a 10-year cumulative survival rate of 92.5% for pterygoid implants, demonstrating their value in long-term rehabilitation for challen ging patients.
Conclusion
The global zygomatic and pterygoid implants market is poised for steady growth, driven by the rising demand for advanced solutions for severe maxillary bone loss and full-arch dental rehabilitation. Innovations in digital treatment planning, CBCT imaging, guided surgery, and immediate loading protocols are improving clinical outcomes while reducing treatment complexity and recovery time. Titanium implants continue to dominate due to their proven durability and biocompatibility, while dental clinics remain the primary end users. With North America leading market adoption and increasing preference for graftless implant procedures worldwide, zygomatic and pterygoid implants are expected to play an increasingly important role in modern implant dentistry, offering patients reliable, long-lasting, and minimally invasive restorative solutions.
Top comments (0)